PXS — Provexis Balance Sheet
0.000.00%
- £14.08m
- £13.06m
- £0.80m
Annual balance sheet for Provexis, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.291 | 1.08 | 0.864 | 0.379 | 0.189 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.167 | 0.05 | 0.117 | 0.122 | 0.158 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.469 | 1.29 | 1.13 | 0.846 | 0.498 |
Total Assets | 0.469 | 1.29 | 1.13 | 0.846 | 0.498 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.15 | 0.151 | 0.158 | 0.188 | 0.307 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | -0.346 | -0.363 | -0.372 | -0.344 | -0.226 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.814 | 1.66 | 1.5 | 1.19 | 0.724 |
Total Liabilities & Shareholders' Equity | 0.469 | 1.29 | 1.13 | 0.846 | 0.498 |
Total Common Shares Outstanding |